abstract |
The present invention is directed to compounds according to Formula (I) and the pharmaceutically acceptable salts thereof. The compounds can be used as modulators of Estrogen-related Receptor alpha (ERRĪ±) and have utility in the treatment of ERRĪ±-mediated diseases or conditions. |